Biocorrx Inc.

Anaheim, CA

UEI
M66BMLPTXSM1
CAGE
836P1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2390 E Orangewood Ave # 570, Anaheim, CA 92806, USA
Website
biocorrx.com
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a 3-month implantable depot pellet of naltrexone for the treatment of opioid use disorder. - biocorrx is… UH3DA047925 National Institute on Drug Abuse (NIH) $10,658,394
Development of a 3-month implantable depot pellet of naltrexone for the treatment of opioid use disorder. UG3DA047925 National Institute on Drug Abuse (NIH) $5,674,268

Quick answers

Is Biocorrx Inc. registered in SAM.gov?

Yes. Biocorrx Inc.'s SAM.gov registration is active through July 28, 2027.

What is Biocorrx Inc.'s most recent federal award?

Biocorrx Inc.'s most recent federal grant award is Development of a 3-month implantable depot pellet of naltrexone for the treatment of opioid use disorder. - biocorrx is… (UH3DA047925), from National Institute on Drug Abuse (NIH), on March 1, 2022.

On GovTribe

See Biocorrx Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login